BOSTON--(BUSINESS WIRE)--Jun. 28, 2018-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the second quarter ended June 30, 2018 before the US financial markets open on July 26, 2018. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast at 8:00 a.m. Eastern Time (ET).
To participate in this conference call, dial 866-762-3111 (USA) or 210-874-7712 (International), conference ID 9096048 shortly before 8:00 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.
[ALXN-G]
View source version on businesswire.com: https://www.businesswire.com/news/home/20180628006014/en/
Source: Alexion Pharmaceuticals, Inc.
Investors
Alexion Pharmaceuticals, Inc.
Susan Altschuller, Ph.D.
Vice President, Investor Relations
(857) 338-8788